nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—CYP11B1—Hydrocortisone—psoriasis	0.0918	0.118	CbGbCtD
Cimetidine—ABCB11—Cyclosporine—psoriasis	0.0416	0.0534	CbGbCtD
Cimetidine—CYP2C8—Tazarotene—psoriasis	0.0376	0.0482	CbGbCtD
Cimetidine—CYP3A5—Beclomethasone—psoriasis	0.0363	0.0466	CbGbCtD
Cimetidine—CYP1A2—Clobetasol propionate—psoriasis	0.0357	0.0458	CbGbCtD
Cimetidine—ABCB11—Dexamethasone—psoriasis	0.0274	0.0352	CbGbCtD
Cimetidine—SLC22A11—Methotrexate—psoriasis	0.0209	0.0268	CbGbCtD
Cimetidine—SLC22A7—Methotrexate—psoriasis	0.0199	0.0256	CbGbCtD
Cimetidine—CYP1A2—Methoxsalen—psoriasis	0.0187	0.0241	CbGbCtD
Cimetidine—CYP2D6—Hydroxyurea—psoriasis	0.0169	0.0217	CbGbCtD
Cimetidine—CYP2C8—Cholecalciferol—psoriasis	0.016	0.0206	CbGbCtD
Cimetidine—SLC22A6—Cyclosporine—psoriasis	0.016	0.0206	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0155	0.0199	CbGbCtD
Cimetidine—CYP3A7—Hydrocortisone—psoriasis	0.0155	0.0199	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0146	0.0188	CbGbCtD
Cimetidine—CYP3A7—Cyclosporine—psoriasis	0.0146	0.0188	CbGbCtD
Cimetidine—CYP3A5—Mycophenolate mofetil—psoriasis	0.0145	0.0186	CbGbCtD
Cimetidine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0139	0.0178	CbGbCtD
Cimetidine—CYP2C19—Cholecalciferol—psoriasis	0.0135	0.0173	CbGbCtD
Cimetidine—CYP3A4—Calcitriol—psoriasis	0.0126	0.0162	CbGbCtD
Cimetidine—SLC22A8—Methotrexate—psoriasis	0.0122	0.0156	CbGbCtD
Cimetidine—CYP3A5—Hydrocortisone—psoriasis	0.0116	0.0149	CbGbCtD
Cimetidine—CYP2C9—Cholecalciferol—psoriasis	0.0112	0.0144	CbGbCtD
Cimetidine—CYP2C8—Hydrocortisone—psoriasis	0.0112	0.0143	CbGbCtD
Cimetidine—CYP3A5—Cyclosporine—psoriasis	0.011	0.0141	CbGbCtD
Cimetidine—CYP2C8—Cyclosporine—psoriasis	0.0105	0.0135	CbGbCtD
Cimetidine—CYP2D6—Cholecalciferol—psoriasis	0.0102	0.0131	CbGbCtD
Cimetidine—CYP3A4—Methoxsalen—psoriasis	0.00982	0.0126	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00963	0.0124	CbGbCtD
Cimetidine—CYP3A7—Dexamethasone—psoriasis	0.00963	0.0124	CbGbCtD
Cimetidine—ABCB1—Mycophenolate mofetil—psoriasis	0.00942	0.0121	CbGbCtD
Cimetidine—CYP2C19—Prednisone—psoriasis	0.00933	0.012	CbGbCtD
Cimetidine—CYP2E1—Dexamethasone—psoriasis	0.00929	0.0119	CbGbCtD
Cimetidine—FMO3—sweat—psoriasis	0.00902	0.791	CbGeAlD
Cimetidine—CYP2C19—Cyclosporine—psoriasis	0.00884	0.0113	CbGbCtD
Cimetidine—SLC22A6—Methotrexate—psoriasis	0.00848	0.0109	CbGbCtD
Cimetidine—ABCB1—Betamethasone—psoriasis	0.00808	0.0104	CbGbCtD
Cimetidine—ABCB1—Prednisolone—psoriasis	0.00797	0.0102	CbGbCtD
Cimetidine—ABCB1—Hydrocortisone—psoriasis	0.00756	0.0097	CbGbCtD
Cimetidine—ABCB1—Prednisone—psoriasis	0.00753	0.00966	CbGbCtD
Cimetidine—CYP2C9—Cyclosporine—psoriasis	0.00735	0.00944	CbGbCtD
Cimetidine—CYP3A5—Dexamethasone—psoriasis	0.00722	0.00927	CbGbCtD
Cimetidine—ABCB1—Cyclosporine—psoriasis	0.00714	0.00916	CbGbCtD
Cimetidine—CYP2C8—Dexamethasone—psoriasis	0.00694	0.00891	CbGbCtD
Cimetidine—CYP2D6—Cyclosporine—psoriasis	0.00672	0.00863	CbGbCtD
Cimetidine—CYP3A4—Cholecalciferol—psoriasis	0.00651	0.00835	CbGbCtD
Cimetidine—CYP2C19—Dexamethasone—psoriasis	0.00582	0.00747	CbGbCtD
Cimetidine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00564	0.00724	CbGbCtD
Cimetidine—CYP3A4—Triamcinolone—psoriasis	0.00564	0.00724	CbGbCtD
Cimetidine—CYP2C9—Dexamethasone—psoriasis	0.00484	0.00621	CbGbCtD
Cimetidine—CYP3A4—Betamethasone—psoriasis	0.00484	0.00621	CbGbCtD
Cimetidine—CYP3A4—Prednisolone—psoriasis	0.00478	0.00613	CbGbCtD
Cimetidine—ABCB1—Dexamethasone—psoriasis	0.0047	0.00603	CbGbCtD
Cimetidine—CYP3A4—Hydrocortisone—psoriasis	0.00453	0.00581	CbGbCtD
Cimetidine—CYP3A4—Prednisone—psoriasis	0.00451	0.00579	CbGbCtD
Cimetidine—CYP2D6—Dexamethasone—psoriasis	0.00443	0.00568	CbGbCtD
Cimetidine—CYP3A4—Cyclosporine—psoriasis	0.00428	0.00549	CbGbCtD
Cimetidine—ABCB1—Methotrexate—psoriasis	0.00378	0.00485	CbGbCtD
Cimetidine—CYP3A4—Dexamethasone—psoriasis	0.00282	0.00361	CbGbCtD
Cimetidine—HRH2—skin of body—psoriasis	0.000573	0.0503	CbGeAlD
Cimetidine—FMO1—tendon—psoriasis	0.000567	0.0497	CbGeAlD
Cimetidine—SLC47A1—tendon—psoriasis	0.000337	0.0295	CbGeAlD
Cimetidine—SLC22A4—tendon—psoriasis	0.000295	0.0259	CbGeAlD
Cimetidine—Diarrhoea—Acitretin—psoriasis	0.000272	0.00178	CcSEcCtD
Cimetidine—Anxiety—Mycophenolic acid—psoriasis	0.000271	0.00178	CcSEcCtD
Cimetidine—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000271	0.00177	CcSEcCtD
Cimetidine—Bradycardia—Hydrocortisone—psoriasis	0.000269	0.00176	CcSEcCtD
Cimetidine—Fatigue—Hydroxyurea—psoriasis	0.000269	0.00176	CcSEcCtD
Cimetidine—Constipation—Hydroxyurea—psoriasis	0.000267	0.00174	CcSEcCtD
Cimetidine—Nausea—Calcitriol—psoriasis	0.000265	0.00174	CcSEcCtD
Cimetidine—Hepatic failure—Methotrexate—psoriasis	0.000264	0.00173	CcSEcCtD
Cimetidine—Confusional state—Mycophenolic acid—psoriasis	0.000263	0.00172	CcSEcCtD
Cimetidine—Hallucination—Hydrocortisone—psoriasis	0.000263	0.00172	CcSEcCtD
Cimetidine—Alopecia—Cyclosporine—psoriasis	0.000263	0.00172	CcSEcCtD
Cimetidine—Dizziness—Acitretin—psoriasis	0.000263	0.00172	CcSEcCtD
Cimetidine—Dizziness—Fluocinolone Acetonide—psoriasis	0.000262	0.00171	CcSEcCtD
Cimetidine—Feeling abnormal—Hydroxyurea—psoriasis	0.000257	0.00168	CcSEcCtD
Cimetidine—SLC22A5—skin of body—psoriasis	0.000257	0.0225	CbGeAlD
Cimetidine—Alopecia—Mycophenolate mofetil—psoriasis	0.000256	0.00168	CcSEcCtD
Cimetidine—Thrombocytopenia—Mycophenolic acid—psoriasis	0.000256	0.00167	CcSEcCtD
Cimetidine—Flatulence—Cyclosporine—psoriasis	0.000255	0.00167	CcSEcCtD
Cimetidine—Tachycardia—Mycophenolic acid—psoriasis	0.000255	0.00167	CcSEcCtD
Cimetidine—Bradycardia—Triamcinolone—psoriasis	0.000253	0.00166	CcSEcCtD
Cimetidine—Vomiting—Acitretin—psoriasis	0.000253	0.00165	CcSEcCtD
Cimetidine—Vomiting—Fluocinolone Acetonide—psoriasis	0.000252	0.00165	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Methotrexate—psoriasis	0.000252	0.00165	CcSEcCtD
Cimetidine—Rash—Acitretin—psoriasis	0.00025	0.00164	CcSEcCtD
Cimetidine—Dermatitis—Acitretin—psoriasis	0.00025	0.00164	CcSEcCtD
Cimetidine—Rash—Fluocinolone Acetonide—psoriasis	0.00025	0.00163	CcSEcCtD
Cimetidine—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000249	0.00163	CcSEcCtD
Cimetidine—Flatulence—Mycophenolate mofetil—psoriasis	0.000249	0.00163	CcSEcCtD
Cimetidine—Headache—Acitretin—psoriasis	0.000249	0.00163	CcSEcCtD
Cimetidine—Headache—Fluocinolone Acetonide—psoriasis	0.000248	0.00162	CcSEcCtD
Cimetidine—Body temperature increased—Hydroxyurea—psoriasis	0.000246	0.00161	CcSEcCtD
Cimetidine—Pancreatitis—Prednisone—psoriasis	0.000241	0.00158	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.000238	0.00156	CcSEcCtD
Cimetidine—Agitation—Cyclosporine—psoriasis	0.000238	0.00156	CcSEcCtD
Cimetidine—Nausea—Acitretin—psoriasis	0.000236	0.00154	CcSEcCtD
Cimetidine—Nausea—Fluocinolone Acetonide—psoriasis	0.000235	0.00154	CcSEcCtD
Cimetidine—Malaise—Cyclosporine—psoriasis	0.000233	0.00153	CcSEcCtD
Cimetidine—Somnolence—Mycophenolic acid—psoriasis	0.000232	0.00152	CcSEcCtD
Cimetidine—Agitation—Mycophenolate mofetil—psoriasis	0.000232	0.00152	CcSEcCtD
Cimetidine—Leukopenia—Cyclosporine—psoriasis	0.000232	0.00152	CcSEcCtD
Cimetidine—Bradycardia—Dexamethasone—psoriasis	0.00023	0.0015	CcSEcCtD
Cimetidine—Bradycardia—Betamethasone—psoriasis	0.00023	0.0015	CcSEcCtD
Cimetidine—Hypersensitivity—Hydroxyurea—psoriasis	0.00023	0.0015	CcSEcCtD
Cimetidine—Neutropenia—Prednisone—psoriasis	0.00023	0.0015	CcSEcCtD
Cimetidine—Malaise—Mycophenolate mofetil—psoriasis	0.000228	0.00149	CcSEcCtD
Cimetidine—Erectile dysfunction—Prednisone—psoriasis	0.000226	0.00148	CcSEcCtD
Cimetidine—Leukopenia—Mycophenolate mofetil—psoriasis	0.000226	0.00148	CcSEcCtD
Cimetidine—Fatigue—Mycophenolic acid—psoriasis	0.000225	0.00147	CcSEcCtD
Cimetidine—Hallucination—Dexamethasone—psoriasis	0.000225	0.00147	CcSEcCtD
Cimetidine—Hallucination—Betamethasone—psoriasis	0.000225	0.00147	CcSEcCtD
Cimetidine—Asthenia—Hydroxyurea—psoriasis	0.000224	0.00146	CcSEcCtD
Cimetidine—Constipation—Mycophenolic acid—psoriasis	0.000223	0.00146	CcSEcCtD
Cimetidine—Arthralgia—Cyclosporine—psoriasis	0.00022	0.00144	CcSEcCtD
Cimetidine—Myalgia—Cyclosporine—psoriasis	0.00022	0.00144	CcSEcCtD
Cimetidine—Anxiety—Cyclosporine—psoriasis	0.00022	0.00144	CcSEcCtD
Cimetidine—Feeling abnormal—Mycophenolic acid—psoriasis	0.000215	0.00141	CcSEcCtD
Cimetidine—Arthralgia—Mycophenolate mofetil—psoriasis	0.000215	0.00141	CcSEcCtD
Cimetidine—Myalgia—Mycophenolate mofetil—psoriasis	0.000215	0.00141	CcSEcCtD
Cimetidine—Anxiety—Mycophenolate mofetil—psoriasis	0.000214	0.0014	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Methotrexate—psoriasis	0.000214	0.0014	CcSEcCtD
Cimetidine—Diarrhoea—Hydroxyurea—psoriasis	0.000213	0.0014	CcSEcCtD
Cimetidine—Confusional state—Cyclosporine—psoriasis	0.000213	0.00139	CcSEcCtD
Cimetidine—Malaise—Prednisolone—psoriasis	0.000212	0.00139	CcSEcCtD
Cimetidine—Anaphylactic shock—Cyclosporine—psoriasis	0.000211	0.00138	CcSEcCtD
Cimetidine—Confusional state—Mycophenolate mofetil—psoriasis	0.000208	0.00136	CcSEcCtD
Cimetidine—Malaise—Hydrocortisone—psoriasis	0.000207	0.00136	CcSEcCtD
Cimetidine—Thrombocytopenia—Cyclosporine—psoriasis	0.000207	0.00135	CcSEcCtD
Cimetidine—Body temperature increased—Mycophenolic acid—psoriasis	0.000206	0.00135	CcSEcCtD
Cimetidine—Dizziness—Hydroxyurea—psoriasis	0.000206	0.00135	CcSEcCtD
Cimetidine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000206	0.00135	CcSEcCtD
Cimetidine—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000202	0.00132	CcSEcCtD
Cimetidine—Pancreatitis—Methotrexate—psoriasis	0.000201	0.00132	CcSEcCtD
Cimetidine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000201	0.00132	CcSEcCtD
Cimetidine—Bradycardia—Prednisone—psoriasis	0.0002	0.00131	CcSEcCtD
Cimetidine—Alopecia—Dexamethasone—psoriasis	0.0002	0.00131	CcSEcCtD
Cimetidine—Alopecia—Betamethasone—psoriasis	0.0002	0.00131	CcSEcCtD
Cimetidine—Vomiting—Hydroxyurea—psoriasis	0.000198	0.0013	CcSEcCtD
Cimetidine—Rash—Hydroxyurea—psoriasis	0.000197	0.00129	CcSEcCtD
Cimetidine—Dermatitis—Hydroxyurea—psoriasis	0.000196	0.00129	CcSEcCtD
Cimetidine—Myalgia—Hydrocortisone—psoriasis	0.000196	0.00128	CcSEcCtD
Cimetidine—Hallucination—Prednisone—psoriasis	0.000196	0.00128	CcSEcCtD
Cimetidine—Malaise—Triamcinolone—psoriasis	0.000195	0.00128	CcSEcCtD
Cimetidine—Headache—Hydroxyurea—psoriasis	0.000195	0.00128	CcSEcCtD
Cimetidine—SLC22A5—tendon—psoriasis	0.000195	0.0171	CbGeAlD
Cimetidine—Anxiety—Hydrocortisone—psoriasis	0.000195	0.00128	CcSEcCtD
Cimetidine—Pancytopenia—Methotrexate—psoriasis	0.000195	0.00128	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000192	0.00126	CcSEcCtD
Cimetidine—Anaphylactic shock—Prednisolone—psoriasis	0.000192	0.00126	CcSEcCtD
Cimetidine—Neutropenia—Methotrexate—psoriasis	0.000192	0.00126	CcSEcCtD
Cimetidine—Erectile dysfunction—Methotrexate—psoriasis	0.000189	0.00124	CcSEcCtD
Cimetidine—Somnolence—Cyclosporine—psoriasis	0.000188	0.00123	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000188	0.00123	CcSEcCtD
Cimetidine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000188	0.00123	CcSEcCtD
Cimetidine—Tachycardia—Prednisolone—psoriasis	0.000188	0.00123	CcSEcCtD
Cimetidine—Asthenia—Mycophenolic acid—psoriasis	0.000187	0.00123	CcSEcCtD
Cimetidine—Nausea—Hydroxyurea—psoriasis	0.000185	0.00121	CcSEcCtD
Cimetidine—Myalgia—Triamcinolone—psoriasis	0.000184	0.00121	CcSEcCtD
Cimetidine—Pneumonia—Methotrexate—psoriasis	0.000184	0.0012	CcSEcCtD
Cimetidine—Tachycardia—Hydrocortisone—psoriasis	0.000183	0.0012	CcSEcCtD
Cimetidine—Somnolence—Mycophenolate mofetil—psoriasis	0.000183	0.0012	CcSEcCtD
Cimetidine—Drowsiness—Methotrexate—psoriasis	0.000183	0.0012	CcSEcCtD
Cimetidine—Fatigue—Cyclosporine—psoriasis	0.000182	0.00119	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.000181	0.00119	CcSEcCtD
Cimetidine—Constipation—Cyclosporine—psoriasis	0.000181	0.00118	CcSEcCtD
Cimetidine—Renal failure—Methotrexate—psoriasis	0.00018	0.00118	CcSEcCtD
Cimetidine—Diarrhoea—Mycophenolic acid—psoriasis	0.000179	0.00117	CcSEcCtD
Cimetidine—Malaise—Betamethasone—psoriasis	0.000177	0.00116	CcSEcCtD
Cimetidine—Malaise—Dexamethasone—psoriasis	0.000177	0.00116	CcSEcCtD
Cimetidine—Anaphylactic shock—Triamcinolone—psoriasis	0.000177	0.00116	CcSEcCtD
Cimetidine—Constipation—Mycophenolate mofetil—psoriasis	0.000176	0.00115	CcSEcCtD
Cimetidine—Feeling abnormal—Cyclosporine—psoriasis	0.000174	0.00114	CcSEcCtD
Cimetidine—Alopecia—Prednisone—psoriasis	0.000174	0.00114	CcSEcCtD
Cimetidine—Dizziness—Mycophenolic acid—psoriasis	0.000173	0.00113	CcSEcCtD
Cimetidine—Tachycardia—Triamcinolone—psoriasis	0.000173	0.00113	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000171	0.00112	CcSEcCtD
Cimetidine—Agranulocytosis—Methotrexate—psoriasis	0.000171	0.00112	CcSEcCtD
Cimetidine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.00017	0.00111	CcSEcCtD
Cimetidine—Myalgia—Dexamethasone—psoriasis	0.000167	0.00109	CcSEcCtD
Cimetidine—Myalgia—Betamethasone—psoriasis	0.000167	0.00109	CcSEcCtD
Cimetidine—Body temperature increased—Cyclosporine—psoriasis	0.000167	0.00109	CcSEcCtD
Cimetidine—Anxiety—Dexamethasone—psoriasis	0.000167	0.00109	CcSEcCtD
Cimetidine—Anxiety—Betamethasone—psoriasis	0.000167	0.00109	CcSEcCtD
Cimetidine—Vomiting—Mycophenolic acid—psoriasis	0.000166	0.00109	CcSEcCtD
Cimetidine—Rash—Mycophenolic acid—psoriasis	0.000165	0.00108	CcSEcCtD
Cimetidine—Dermatitis—Mycophenolic acid—psoriasis	0.000165	0.00108	CcSEcCtD
Cimetidine—Hepatitis—Methotrexate—psoriasis	0.000164	0.00108	CcSEcCtD
Cimetidine—Headache—Mycophenolic acid—psoriasis	0.000164	0.00107	CcSEcCtD
Cimetidine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000163	0.00107	CcSEcCtD
Cimetidine—Fatigue—Hydrocortisone—psoriasis	0.000162	0.00106	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000161	0.00105	CcSEcCtD
Cimetidine—Anaphylactic shock—Dexamethasone—psoriasis	0.00016	0.00105	CcSEcCtD
Cimetidine—Anaphylactic shock—Betamethasone—psoriasis	0.00016	0.00105	CcSEcCtD
Cimetidine—CYP2E1—tendon—psoriasis	0.000159	0.014	CbGeAlD
Cimetidine—Feeling abnormal—Prednisolone—psoriasis	0.000158	0.00104	CcSEcCtD
Cimetidine—Agitation—Prednisone—psoriasis	0.000157	0.00103	CcSEcCtD
Cimetidine—Thrombocytopenia—Betamethasone—psoriasis	0.000157	0.00103	CcSEcCtD
Cimetidine—Thrombocytopenia—Dexamethasone—psoriasis	0.000157	0.00103	CcSEcCtD
Cimetidine—Tachycardia—Betamethasone—psoriasis	0.000157	0.00102	CcSEcCtD
Cimetidine—Tachycardia—Dexamethasone—psoriasis	0.000157	0.00102	CcSEcCtD
Cimetidine—Hypersensitivity—Cyclosporine—psoriasis	0.000156	0.00102	CcSEcCtD
Cimetidine—Erythema multiforme—Methotrexate—psoriasis	0.000155	0.00102	CcSEcCtD
Cimetidine—Nausea—Mycophenolic acid—psoriasis	0.000155	0.00101	CcSEcCtD
Cimetidine—Feeling abnormal—Hydrocortisone—psoriasis	0.000155	0.00101	CcSEcCtD
Cimetidine—Malaise—Prednisone—psoriasis	0.000154	0.00101	CcSEcCtD
Cimetidine—SLC22A7—SLC-mediated transmembrane transport—CP—psoriasis	0.000153	0.00272	CbGpPWpGaD
Cimetidine—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000153	0.00271	CbGpPWpGaD
Cimetidine—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000153	0.00271	CbGpPWpGaD
Cimetidine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000152	0.0027	CbGpPWpGaD
Cimetidine—Fatigue—Triamcinolone—psoriasis	0.000152	0.000997	CcSEcCtD
Cimetidine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000152	0.000994	CcSEcCtD
Cimetidine—Asthenia—Cyclosporine—psoriasis	0.000152	0.000992	CcSEcCtD
Cimetidine—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000151	0.00267	CbGpPWpGaD
Cimetidine—SLC22A7—Fluoropyrimidine Activity—TP53—psoriasis	0.000149	0.00264	CbGpPWpGaD
Cimetidine—Body temperature increased—Hydrocortisone—psoriasis	0.000148	0.000971	CcSEcCtD
Cimetidine—Asthenia—Mycophenolate mofetil—psoriasis	0.000148	0.000968	CcSEcCtD
Cimetidine—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000147	0.0026	CbGpPWpGaD
Cimetidine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000146	0.000956	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000146	0.000956	CcSEcCtD
Cimetidine—Myalgia—Prednisone—psoriasis	0.000146	0.000954	CcSEcCtD
Cimetidine—Arthralgia—Prednisone—psoriasis	0.000146	0.000954	CcSEcCtD
Cimetidine—Feeling abnormal—Triamcinolone—psoriasis	0.000146	0.000953	CcSEcCtD
Cimetidine—Anxiety—Prednisone—psoriasis	0.000145	0.00095	CcSEcCtD
Cimetidine—Alopecia—Methotrexate—psoriasis	0.000145	0.00095	CcSEcCtD
Cimetidine—Diarrhoea—Cyclosporine—psoriasis	0.000145	0.000946	CcSEcCtD
Cimetidine—FMO1—Metabolism—CYP2S1—psoriasis	0.000144	0.00256	CbGpPWpGaD
Cimetidine—SLC22A3—SLC-mediated transmembrane transport—CP—psoriasis	0.000143	0.00254	CbGpPWpGaD
Cimetidine—SLC22A5—SLC-mediated transmembrane transport—CP—psoriasis	0.000143	0.00253	CbGpPWpGaD
Cimetidine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000142	0.00252	CbGpPWpGaD
Cimetidine—Hypersensitivity—Prednisolone—psoriasis	0.000142	0.000927	CcSEcCtD
Cimetidine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000141	0.000923	CcSEcCtD
Cimetidine—Body temperature increased—Triamcinolone—psoriasis	0.00014	0.000914	CcSEcCtD
Cimetidine—Dizziness—Cyclosporine—psoriasis	0.00014	0.000914	CcSEcCtD
Cimetidine—Anaphylactic shock—Prednisone—psoriasis	0.00014	0.000914	CcSEcCtD
Cimetidine—SLC47A1—Transmembrane transport of small molecules—CP—psoriasis	0.000139	0.00246	CbGpPWpGaD
Cimetidine—Hypersensitivity—Hydrocortisone—psoriasis	0.000138	0.000905	CcSEcCtD
Cimetidine—Fatigue—Betamethasone—psoriasis	0.000138	0.000905	CcSEcCtD
Cimetidine—Fatigue—Dexamethasone—psoriasis	0.000138	0.000905	CcSEcCtD
Cimetidine—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000137	0.00242	CbGpPWpGaD
Cimetidine—Tachycardia—Prednisone—psoriasis	0.000136	0.000892	CcSEcCtD
Cimetidine—Dizziness—Mycophenolate mofetil—psoriasis	0.000136	0.000892	CcSEcCtD
Cimetidine—Asthenia—Hydrocortisone—psoriasis	0.000135	0.000881	CcSEcCtD
Cimetidine—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000135	0.00239	CbGpPWpGaD
Cimetidine—Vomiting—Cyclosporine—psoriasis	0.000134	0.000879	CcSEcCtD
Cimetidine—Rash—Cyclosporine—psoriasis	0.000133	0.000872	CcSEcCtD
Cimetidine—Dermatitis—Cyclosporine—psoriasis	0.000133	0.000871	CcSEcCtD
Cimetidine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000133	0.00235	CbGpPWpGaD
Cimetidine—SLC47A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000133	0.00235	CbGpPWpGaD
Cimetidine—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000132	0.00235	CbGpPWpGaD
Cimetidine—Headache—Cyclosporine—psoriasis	0.000132	0.000866	CcSEcCtD
Cimetidine—Feeling abnormal—Betamethasone—psoriasis	0.000132	0.000865	CcSEcCtD
Cimetidine—Feeling abnormal—Dexamethasone—psoriasis	0.000132	0.000865	CcSEcCtD
Cimetidine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000132	0.00233	CbGpPWpGaD
Cimetidine—Vomiting—Mycophenolate mofetil—psoriasis	0.000131	0.000857	CcSEcCtD
Cimetidine—Hypersensitivity—Triamcinolone—psoriasis	0.00013	0.000852	CcSEcCtD
Cimetidine—Rash—Mycophenolate mofetil—psoriasis	0.00013	0.00085	CcSEcCtD
Cimetidine—Dermatitis—Mycophenolate mofetil—psoriasis	0.00013	0.000849	CcSEcCtD
Cimetidine—Headache—Mycophenolate mofetil—psoriasis	0.000129	0.000845	CcSEcCtD
Cimetidine—Malaise—Methotrexate—psoriasis	0.000129	0.000844	CcSEcCtD
Cimetidine—SLC22A8—SLC-mediated transmembrane transport—CP—psoriasis	0.000129	0.00229	CbGpPWpGaD
Cimetidine—Diarrhoea—Hydrocortisone—psoriasis	0.000128	0.000841	CcSEcCtD
Cimetidine—Leukopenia—Methotrexate—psoriasis	0.000128	0.000838	CcSEcCtD
Cimetidine—HRH2—GPCR downstream signaling—HCAR2—psoriasis	0.000127	0.00226	CbGpPWpGaD
Cimetidine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000127	0.000833	CcSEcCtD
Cimetidine—Dizziness—Prednisolone—psoriasis	0.000127	0.000832	CcSEcCtD
Cimetidine—CYP11B1—Corticotropin-releasing hormone—CXCL8—psoriasis	0.000127	0.00225	CbGpPWpGaD
Cimetidine—Asthenia—Triamcinolone—psoriasis	0.000127	0.00083	CcSEcCtD
Cimetidine—Body temperature increased—Betamethasone—psoriasis	0.000127	0.00083	CcSEcCtD
Cimetidine—Body temperature increased—Dexamethasone—psoriasis	0.000127	0.00083	CcSEcCtD
Cimetidine—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000126	0.00223	CbGpPWpGaD
Cimetidine—Nausea—Cyclosporine—psoriasis	0.000125	0.000821	CcSEcCtD
Cimetidine—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000125	0.00221	CbGpPWpGaD
Cimetidine—Dizziness—Hydrocortisone—psoriasis	0.000124	0.000812	CcSEcCtD
Cimetidine—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000124	0.00219	CbGpPWpGaD
Cimetidine—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000123	0.00218	CbGpPWpGaD
Cimetidine—Nausea—Mycophenolate mofetil—psoriasis	0.000122	0.000801	CcSEcCtD
Cimetidine—Arthralgia—Methotrexate—psoriasis	0.000122	0.000797	CcSEcCtD
Cimetidine—Myalgia—Methotrexate—psoriasis	0.000122	0.000797	CcSEcCtD
Cimetidine—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000122	0.00216	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—NDUFA5—psoriasis	0.000121	0.00215	CbGpPWpGaD
Cimetidine—Rash—Prednisolone—psoriasis	0.000121	0.000793	CcSEcCtD
Cimetidine—Dermatitis—Prednisolone—psoriasis	0.000121	0.000792	CcSEcCtD
Cimetidine—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000121	0.00215	CbGpPWpGaD
Cimetidine—Fatigue—Prednisone—psoriasis	0.00012	0.000788	CcSEcCtD
Cimetidine—Headache—Prednisolone—psoriasis	0.00012	0.000788	CcSEcCtD
Cimetidine—Constipation—Prednisone—psoriasis	0.000119	0.000782	CcSEcCtD
Cimetidine—Vomiting—Hydrocortisone—psoriasis	0.000119	0.000781	CcSEcCtD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000119	0.0021	CbGpPWpGaD
Cimetidine—Rash—Hydrocortisone—psoriasis	0.000118	0.000775	CcSEcCtD
Cimetidine—Dermatitis—Hydrocortisone—psoriasis	0.000118	0.000774	CcSEcCtD
Cimetidine—Confusional state—Methotrexate—psoriasis	0.000118	0.00077	CcSEcCtD
Cimetidine—Headache—Hydrocortisone—psoriasis	0.000118	0.00077	CcSEcCtD
Cimetidine—HRH2—GPCR ligand binding—CCL20—psoriasis	0.000117	0.00207	CbGpPWpGaD
Cimetidine—Dizziness—Triamcinolone—psoriasis	0.000117	0.000765	CcSEcCtD
Cimetidine—Anaphylactic shock—Methotrexate—psoriasis	0.000117	0.000764	CcSEcCtD
Cimetidine—HRH2—Signaling by GPCR—HCAR2—psoriasis	0.000116	0.00205	CbGpPWpGaD
Cimetidine—Feeling abnormal—Prednisone—psoriasis	0.000115	0.000753	CcSEcCtD
Cimetidine—Asthenia—Betamethasone—psoriasis	0.000115	0.000753	CcSEcCtD
Cimetidine—Asthenia—Dexamethasone—psoriasis	0.000115	0.000753	CcSEcCtD
Cimetidine—Thrombocytopenia—Methotrexate—psoriasis	0.000114	0.000748	CcSEcCtD
Cimetidine—Nausea—Prednisolone—psoriasis	0.000114	0.000747	CcSEcCtD
Cimetidine—CYP11B1—Corticotropin-releasing hormone—NFKB1—psoriasis	0.000114	0.00201	CbGpPWpGaD
Cimetidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000113	0.00201	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000113	0.00201	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—IL13—psoriasis	0.000113	0.002	CbGpPWpGaD
Cimetidine—Vomiting—Triamcinolone—psoriasis	0.000112	0.000735	CcSEcCtD
Cimetidine—Nausea—Hydrocortisone—psoriasis	0.000112	0.00073	CcSEcCtD
Cimetidine—Rash—Triamcinolone—psoriasis	0.000111	0.000729	CcSEcCtD
Cimetidine—Dermatitis—Triamcinolone—psoriasis	0.000111	0.000729	CcSEcCtD
Cimetidine—Headache—Triamcinolone—psoriasis	0.000111	0.000725	CcSEcCtD
Cimetidine—Body temperature increased—Prednisone—psoriasis	0.00011	0.000723	CcSEcCtD
Cimetidine—Diarrhoea—Betamethasone—psoriasis	0.00011	0.000718	CcSEcCtD
Cimetidine—Diarrhoea—Dexamethasone—psoriasis	0.00011	0.000718	CcSEcCtD
Cimetidine—SLC22A6—SLC-mediated transmembrane transport—CP—psoriasis	0.000108	0.00191	CbGpPWpGaD
Cimetidine—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000106	0.00189	CbGpPWpGaD
Cimetidine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000106	0.000696	CcSEcCtD
Cimetidine—Dizziness—Betamethasone—psoriasis	0.000106	0.000694	CcSEcCtD
Cimetidine—Dizziness—Dexamethasone—psoriasis	0.000106	0.000694	CcSEcCtD
Cimetidine—Nausea—Triamcinolone—psoriasis	0.000105	0.000687	CcSEcCtD
Cimetidine—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000105	0.00186	CbGpPWpGaD
Cimetidine—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000105	0.00186	CbGpPWpGaD
Cimetidine—Somnolence—Methotrexate—psoriasis	0.000104	0.000679	CcSEcCtD
Cimetidine—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000104	0.00184	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—CYP2S1—psoriasis	0.000103	0.00183	CbGpPWpGaD
Cimetidine—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000103	0.00183	CbGpPWpGaD
Cimetidine—Hypersensitivity—Prednisone—psoriasis	0.000103	0.000673	CcSEcCtD
Cimetidine—Vomiting—Betamethasone—psoriasis	0.000102	0.000667	CcSEcCtD
Cimetidine—Vomiting—Dexamethasone—psoriasis	0.000102	0.000667	CcSEcCtD
Cimetidine—FMO3—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000101	0.00179	CbGpPWpGaD
Cimetidine—Rash—Betamethasone—psoriasis	0.000101	0.000662	CcSEcCtD
Cimetidine—Rash—Dexamethasone—psoriasis	0.000101	0.000662	CcSEcCtD
Cimetidine—Dermatitis—Dexamethasone—psoriasis	0.000101	0.000661	CcSEcCtD
Cimetidine—Dermatitis—Betamethasone—psoriasis	0.000101	0.000661	CcSEcCtD
Cimetidine—Fatigue—Methotrexate—psoriasis	0.000101	0.000659	CcSEcCtD
Cimetidine—Headache—Dexamethasone—psoriasis	0.0001	0.000658	CcSEcCtD
Cimetidine—Headache—Betamethasone—psoriasis	0.0001	0.000658	CcSEcCtD
Cimetidine—Asthenia—Prednisone—psoriasis	0.0001	0.000656	CcSEcCtD
Cimetidine—CYP11B1—Metabolism—NDUFA5—psoriasis	9.99e-05	0.00177	CbGpPWpGaD
Cimetidine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.91e-05	0.00176	CbGpPWpGaD
Cimetidine—SLC22A4—Transmembrane transport of small molecules—CP—psoriasis	9.64e-05	0.00171	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—IL12B—psoriasis	9.64e-05	0.00171	CbGpPWpGaD
Cimetidine—Feeling abnormal—Methotrexate—psoriasis	9.62e-05	0.00063	CcSEcCtD
Cimetidine—Diarrhoea—Prednisone—psoriasis	9.56e-05	0.000625	CcSEcCtD
Cimetidine—Nausea—Betamethasone—psoriasis	9.53e-05	0.000623	CcSEcCtD
Cimetidine—Nausea—Dexamethasone—psoriasis	9.53e-05	0.000623	CcSEcCtD
Cimetidine—FMO3—SIDS Susceptibility Pathways—JUN—psoriasis	9.41e-05	0.00167	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—HLA-E—psoriasis	9.4e-05	0.00167	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.31e-05	0.00165	CbGpPWpGaD
Cimetidine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.26e-05	0.00164	CbGpPWpGaD
Cimetidine—Dizziness—Prednisone—psoriasis	9.24e-05	0.000604	CcSEcCtD
Cimetidine—Body temperature increased—Methotrexate—psoriasis	9.23e-05	0.000604	CcSEcCtD
Cimetidine—SLC22A4—Transmembrane transport of small molecules—CARM1—psoriasis	9.2e-05	0.00163	CbGpPWpGaD
Cimetidine—CYP1A2—Tryptophan metabolism—CAT—psoriasis	9.18e-05	0.00163	CbGpPWpGaD
Cimetidine—FMO3—SIDS Susceptibility Pathways—NFKB1—psoriasis	9.06e-05	0.00161	CbGpPWpGaD
Cimetidine—SLC22A2—SLC-mediated transmembrane transport—CP—psoriasis	8.97e-05	0.00159	CbGpPWpGaD
Cimetidine—Vomiting—Prednisone—psoriasis	8.88e-05	0.000581	CcSEcCtD
Cimetidine—Rash—Prednisone—psoriasis	8.81e-05	0.000576	CcSEcCtD
Cimetidine—Dermatitis—Prednisone—psoriasis	8.8e-05	0.000576	CcSEcCtD
Cimetidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.76e-05	0.00155	CbGpPWpGaD
Cimetidine—Headache—Prednisone—psoriasis	8.75e-05	0.000573	CcSEcCtD
Cimetidine—Hypersensitivity—Methotrexate—psoriasis	8.6e-05	0.000563	CcSEcCtD
Cimetidine—SLC22A11—Transmembrane transport of small molecules—CP—psoriasis	8.59e-05	0.00152	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—CYP2S1—psoriasis	8.49e-05	0.0015	CbGpPWpGaD
Cimetidine—Asthenia—Methotrexate—psoriasis	8.38e-05	0.000548	CcSEcCtD
Cimetidine—SLC22A1—SLC-mediated transmembrane transport—CP—psoriasis	8.36e-05	0.00148	CbGpPWpGaD
Cimetidine—Nausea—Prednisone—psoriasis	8.3e-05	0.000543	CcSEcCtD
Cimetidine—FMO3—SIDS Susceptibility Pathways—VEGFA—psoriasis	8.22e-05	0.00146	CbGpPWpGaD
Cimetidine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	8.21e-05	0.00146	CbGpPWpGaD
Cimetidine—SLC22A11—Transmembrane transport of small molecules—CARM1—psoriasis	8.2e-05	0.00145	CbGpPWpGaD
Cimetidine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	8.1e-05	0.00144	CbGpPWpGaD
Cimetidine—Diarrhoea—Methotrexate—psoriasis	7.99e-05	0.000523	CcSEcCtD
Cimetidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.91e-05	0.0014	CbGpPWpGaD
Cimetidine—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	7.87e-05	0.0014	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—NDUFA5—psoriasis	7.82e-05	0.00139	CbGpPWpGaD
Cimetidine—SLC22A7—Transmembrane transport of small molecules—CP—psoriasis	7.8e-05	0.00138	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.78e-05	0.00138	CbGpPWpGaD
Cimetidine—Dizziness—Methotrexate—psoriasis	7.72e-05	0.000505	CcSEcCtD
Cimetidine—ABCB11—Metabolism—NDUFA5—psoriasis	7.5e-05	0.00133	CbGpPWpGaD
Cimetidine—SLC22A7—Transmembrane transport of small molecules—CARM1—psoriasis	7.44e-05	0.00132	CbGpPWpGaD
Cimetidine—Vomiting—Methotrexate—psoriasis	7.42e-05	0.000486	CcSEcCtD
Cimetidine—Rash—Methotrexate—psoriasis	7.36e-05	0.000482	CcSEcCtD
Cimetidine—Dermatitis—Methotrexate—psoriasis	7.35e-05	0.000481	CcSEcCtD
Cimetidine—Headache—Methotrexate—psoriasis	7.31e-05	0.000479	CcSEcCtD
Cimetidine—SLC22A3—Transmembrane transport of small molecules—CP—psoriasis	7.27e-05	0.00129	CbGpPWpGaD
Cimetidine—SLC22A5—Transmembrane transport of small molecules—CP—psoriasis	7.25e-05	0.00128	CbGpPWpGaD
Cimetidine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	7.24e-05	0.00128	CbGpPWpGaD
Cimetidine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	7.08e-05	0.00126	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—CARM1—psoriasis	7.05e-05	0.00125	CbGpPWpGaD
Cimetidine—FMO3—SIDS Susceptibility Pathways—TNF—psoriasis	7.05e-05	0.00125	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—IL10—psoriasis	7.05e-05	0.00125	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.99e-05	0.00124	CbGpPWpGaD
Cimetidine—SLC22A3—Transmembrane transport of small molecules—CARM1—psoriasis	6.94e-05	0.00123	CbGpPWpGaD
Cimetidine—Nausea—Methotrexate—psoriasis	6.93e-05	0.000454	CcSEcCtD
Cimetidine—SLC22A5—Transmembrane transport of small molecules—CARM1—psoriasis	6.91e-05	0.00123	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—IL4—psoriasis	6.85e-05	0.00121	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—HCAR2—psoriasis	6.83e-05	0.00121	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.7e-05	0.00119	CbGpPWpGaD
Cimetidine—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.69e-05	0.00119	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—CYP2S1—psoriasis	6.65e-05	0.00118	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—CCL20—psoriasis	6.61e-05	0.00117	CbGpPWpGaD
Cimetidine—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	6.55e-05	0.00116	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—CYP2S1—psoriasis	6.38e-05	0.00113	CbGpPWpGaD
Cimetidine—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	6.25e-05	0.00111	CbGpPWpGaD
Cimetidine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	6.24e-05	0.00111	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—HLA-A—psoriasis	6.21e-05	0.0011	CbGpPWpGaD
Cimetidine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	6.13e-05	0.00109	CbGpPWpGaD
Cimetidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.11e-05	0.00108	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—CCL20—psoriasis	6.01e-05	0.00106	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TAGAP—psoriasis	5.92e-05	0.00105	CbGpPWpGaD
Cimetidine—FMO3—SIDS Susceptibility Pathways—IL6—psoriasis	5.69e-05	0.00101	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.67e-05	0.00101	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	5.47e-05	0.000969	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	5.22e-05	0.000925	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	5.1e-05	0.000903	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—CARM1—psoriasis	5.04e-05	0.000893	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—NDUFA5—psoriasis	4.91e-05	0.000871	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—NDUFA5—psoriasis	4.91e-05	0.000869	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—NDUFA5—psoriasis	4.57e-05	0.00081	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	4.56e-05	0.000808	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.45e-05	0.000789	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	4.41e-05	0.000781	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	4.35e-05	0.000771	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—CAT—psoriasis	4.34e-05	0.000769	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	4.25e-05	0.000753	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.24e-05	0.000752	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—CYP2S1—psoriasis	4.18e-05	0.00074	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—CYP2S1—psoriasis	4.17e-05	0.000739	CbGpPWpGaD
Cimetidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	4.15e-05	0.000735	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—CARM1—psoriasis	4.15e-05	0.000735	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—IFNG—psoriasis	4.14e-05	0.000734	CbGpPWpGaD
Cimetidine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	4.14e-05	0.000733	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	4.05e-05	0.000718	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—CYP2S1—psoriasis	3.89e-05	0.000689	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.88e-05	0.000687	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.85e-05	0.000683	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.85e-05	0.000682	CbGpPWpGaD
Cimetidine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.61e-05	0.00064	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—NDUFA5—psoriasis	3.56e-05	0.000631	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—NDUFA5—psoriasis	3.55e-05	0.000629	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CCL20—psoriasis	3.55e-05	0.000629	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—APOE—psoriasis	3.37e-05	0.000597	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.34e-05	0.000592	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.3e-05	0.000585	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.3e-05	0.000585	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—CARM1—psoriasis	3.25e-05	0.000576	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.17e-05	0.000562	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—CXCL8—psoriasis	3.16e-05	0.00056	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.13e-05	0.000554	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—CARM1—psoriasis	3.11e-05	0.000552	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—CAT—psoriasis	3.1e-05	0.000549	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—NDUFA5—psoriasis	3.08e-05	0.000545	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—CYP2S1—psoriasis	3.03e-05	0.000536	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—CYP2S1—psoriasis	3.02e-05	0.000535	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—PPARG—psoriasis	2.94e-05	0.00052	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.91e-05	0.000516	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.87e-05	0.000508	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—NDUFA5—psoriasis	2.75e-05	0.000487	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—TNF—psoriasis	2.68e-05	0.000475	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—NDUFA5—psoriasis	2.68e-05	0.000475	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.67e-05	0.000472	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CYP2S1—psoriasis	2.62e-05	0.000464	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.56e-05	0.000454	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—CAT—psoriasis	2.55e-05	0.000452	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—NDUFA5—psoriasis	2.53e-05	0.000448	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—NDUFA5—psoriasis	2.5e-05	0.000444	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.49e-05	0.000441	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—APOE—psoriasis	2.41e-05	0.000427	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.38e-05	0.000421	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CYP2S1—psoriasis	2.34e-05	0.000414	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.33e-05	0.000414	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CYP2S1—psoriasis	2.28e-05	0.000404	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CYP2S1—psoriasis	2.15e-05	0.000381	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—NDUFA5—psoriasis	2.14e-05	0.000379	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CYP2S1—psoriasis	2.13e-05	0.000377	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—PPARG—psoriasis	2.1e-05	0.000372	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—CARM1—psoriasis	2.04e-05	0.000362	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—CARM1—psoriasis	2.04e-05	0.000361	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—CAT—psoriasis	2e-05	0.000354	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2e-05	0.000354	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—APOE—psoriasis	1.98e-05	0.000351	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—SOCS1—psoriasis	1.95e-05	0.000346	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—CAT—psoriasis	1.92e-05	0.000339	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—CARM1—psoriasis	1.9e-05	0.000337	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—TYK2—psoriasis	1.86e-05	0.00033	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CYP2S1—psoriasis	1.82e-05	0.000322	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—CXCL8—psoriasis	1.79e-05	0.000316	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.77e-05	0.000313	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PPARG—psoriasis	1.73e-05	0.000306	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.7e-05	0.000301	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.65e-05	0.000293	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—CXCL8—psoriasis	1.62e-05	0.000287	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—APOE—psoriasis	1.55e-05	0.000275	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.54e-05	0.000274	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—APOE—psoriasis	1.49e-05	0.000264	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—CARM1—psoriasis	1.48e-05	0.000262	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—CARM1—psoriasis	1.48e-05	0.000261	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—APOE—psoriasis	1.44e-05	0.000255	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—LEP—psoriasis	1.44e-05	0.000255	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.4e-05	0.000249	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.37e-05	0.000243	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PPARG—psoriasis	1.35e-05	0.00024	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—NFKBIA—psoriasis	1.34e-05	0.000238	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.32e-05	0.000234	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PPARG—psoriasis	1.3e-05	0.00023	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CARM1—psoriasis	1.28e-05	0.000226	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—CAT—psoriasis	1.26e-05	0.000222	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—CAT—psoriasis	1.25e-05	0.000222	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.22e-05	0.000217	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.19e-05	0.000212	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—CAT—psoriasis	1.17e-05	0.000207	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.17e-05	0.000207	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CARM1—psoriasis	1.14e-05	0.000202	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.12e-05	0.000198	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CARM1—psoriasis	1.11e-05	0.000197	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TYK2—psoriasis	1.1e-05	0.000195	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.07e-05	0.000189	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CARM1—psoriasis	1.05e-05	0.000186	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CARM1—psoriasis	1.04e-05	0.000184	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—APOE—psoriasis	9.75e-06	0.000173	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—APOE—psoriasis	9.74e-06	0.000173	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.72e-06	0.000172	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CXCL8—psoriasis	9.58e-06	0.00017	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.54e-06	0.000169	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—IL6—psoriasis	9.11e-06	0.000161	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—CAT—psoriasis	9.09e-06	0.000161	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—APOE—psoriasis	9.08e-06	0.000161	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—CAT—psoriasis	9.07e-06	0.000161	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—JUN—psoriasis	8.91e-06	0.000158	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CARM1—psoriasis	8.89e-06	0.000157	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—NFKB1—psoriasis	8.57e-06	0.000152	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PPARG—psoriasis	8.49e-06	0.000151	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PPARG—psoriasis	8.48e-06	0.00015	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.31e-06	0.000147	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PPARG—psoriasis	7.91e-06	0.00014	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CAT—psoriasis	7.86e-06	0.000139	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—VEGFA—psoriasis	7.78e-06	0.000138	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—STAT3—psoriasis	7.7e-06	0.000137	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—APOE—psoriasis	7.06e-06	0.000125	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—APOE—psoriasis	7.05e-06	0.000125	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CAT—psoriasis	7.01e-06	0.000124	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CARM1—psoriasis	6.86e-06	0.000122	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CAT—psoriasis	6.85e-06	0.000121	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CAT—psoriasis	6.45e-06	0.000114	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CAT—psoriasis	6.4e-06	0.000113	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PPARG—psoriasis	6.15e-06	0.000109	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PPARG—psoriasis	6.14e-06	0.000109	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—APOE—psoriasis	6.11e-06	0.000108	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TP53—psoriasis	5.88e-06	0.000104	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CAT—psoriasis	5.47e-06	9.68e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—APOE—psoriasis	5.45e-06	9.66e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IL6—psoriasis	5.38e-06	9.54e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—APOE—psoriasis	5.32e-06	9.43e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PPARG—psoriasis	5.32e-06	9.42e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—APOE—psoriasis	5.01e-06	8.88e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—APOE—psoriasis	4.97e-06	8.81e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PPARG—psoriasis	4.75e-06	8.41e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PPARG—psoriasis	4.63e-06	8.21e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PPARG—psoriasis	4.37e-06	7.74e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PPARG—psoriasis	4.33e-06	7.67e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—APOE—psoriasis	4.25e-06	7.53e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CAT—psoriasis	4.22e-06	7.47e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PPARG—psoriasis	3.7e-06	6.55e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—APOE—psoriasis	3.28e-06	5.81e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PPARG—psoriasis	2.85e-06	5.06e-05	CbGpPWpGaD
